The Westin Tampa Waterside
Saturday, November 19, 2022
Gastroenterologists, hepatologists, internists, family practitioners, surgeons, physician assistants, nurse practitioners, fellows/residents in training, registered nurses, and other healthcare professionals with an interest in GI and liver diseases.
After completing this activity, the participant should be better able to:
Describe evolving patient management and treatment strategies for CLD and GI disorders.
Integrate significant advances in therapeutic and diagnostic modalities into clinical practice.
Apply the latest clinical research, including future therapies and their role in the context of the current clinical paradigm.
In support of improving patient care, this activity has been planned and implemented by the Annenberg Center for Health Sciences at Eisenhower, the Gastrointestinal and Liver Association of the Americas, and the Texas Liver Institute. The Annenberg Center for Health Sciences at Eisenhower is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 6.50 ANCC contact hours, which will include hours of pharmacology, may be earned for successful completion of this activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) are required to disclose to the audience all relevant financial relationships related to the content of the presentation or enduring material. Full disclosure of all relevant financial relationships will be made in writing to the audience prior to the activity. All other staff at the Annenberg Center for Health Sciences at Eisenhower, the Gastrointestinal and Liver Association of the Americas, and the Texas Liver Institute have no relevant financial relationships to disclose.
LEARNER ASSURANCE STATEMENT
The Annenberg Center for Health Sciences at Eisenhower is committed to mitigating all relevant financial relationships that could arise as a result of individuals who control activity content and who have relevant financial relationships with ACCME-defined ineligible companies. The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those individuals with relevant financial relationships that can be reconciled with the goals and educational integrity of the CE activity.
AMERICANS WITH DISABILITIES ACT
The event staff will be glad to assist you with any special needs (physical, dietary, etc.). Please contact us prior to the event at 877-925-9535 for assistance. Please note: On-site requests will be addressed to the best of our ability.
This activity is supported by educational grants from AbbVie, Gilead Sciences, Inc.,
Mallinckrodt Pharmaceuticals, Phathom Pharmaceuticals, Inc., and Salix Pharmaceuticals.
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower,
the Gastrointestinal and Liver Association of the Americas (GALA) and the Texas Liver Insitute.